Correlation Between Suzhou Novoprotein and Jinhe Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Suzhou Novoprotein and Jinhe Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Suzhou Novoprotein and Jinhe Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Suzhou Novoprotein Scientific and Jinhe Biotechnology Co, you can compare the effects of market volatilities on Suzhou Novoprotein and Jinhe Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Suzhou Novoprotein with a short position of Jinhe Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Suzhou Novoprotein and Jinhe Biotechnology.

Diversification Opportunities for Suzhou Novoprotein and Jinhe Biotechnology

0.94
  Correlation Coefficient

Almost no diversification

The 3 months correlation between Suzhou and Jinhe is 0.94. Overlapping area represents the amount of risk that can be diversified away by holding Suzhou Novoprotein Scientific and Jinhe Biotechnology Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Jinhe Biotechnology and Suzhou Novoprotein is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Suzhou Novoprotein Scientific are associated (or correlated) with Jinhe Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Jinhe Biotechnology has no effect on the direction of Suzhou Novoprotein i.e., Suzhou Novoprotein and Jinhe Biotechnology go up and down completely randomly.

Pair Corralation between Suzhou Novoprotein and Jinhe Biotechnology

Assuming the 90 days trading horizon Suzhou Novoprotein Scientific is expected to under-perform the Jinhe Biotechnology. In addition to that, Suzhou Novoprotein is 1.31 times more volatile than Jinhe Biotechnology Co. It trades about -0.05 of its total potential returns per unit of risk. Jinhe Biotechnology Co is currently generating about 0.0 per unit of volatility. If you would invest  522.00  in Jinhe Biotechnology Co on September 3, 2024 and sell it today you would lose (63.00) from holding Jinhe Biotechnology Co or give up 12.07% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Strong
Accuracy100.0%
ValuesDaily Returns

Suzhou Novoprotein Scientific  vs.  Jinhe Biotechnology Co

 Performance 
       Timeline  
Suzhou Novoprotein 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Suzhou Novoprotein Scientific are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Suzhou Novoprotein sustained solid returns over the last few months and may actually be approaching a breakup point.
Jinhe Biotechnology 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Jinhe Biotechnology Co are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Jinhe Biotechnology sustained solid returns over the last few months and may actually be approaching a breakup point.

Suzhou Novoprotein and Jinhe Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Suzhou Novoprotein and Jinhe Biotechnology

The main advantage of trading using opposite Suzhou Novoprotein and Jinhe Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Suzhou Novoprotein position performs unexpectedly, Jinhe Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Jinhe Biotechnology will offset losses from the drop in Jinhe Biotechnology's long position.
The idea behind Suzhou Novoprotein Scientific and Jinhe Biotechnology Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets